Congress is out of session until Monday, November 9 for the midterm campaign. No new roll-call votes until then; the last were the House on Sep 16 and the Senate on Sep 30.

Money / PACs

Emergent Biosolutions

Corporate PAC FEC C00380303

Influence at a glance · Jan 2025 – Sep 2026Jan 25 – Sep 26 How we count
PAC giving to candidates$37K
Company lobbying, all issues $4.0M

Giving: FEC filings, net of refunds. Lobbying: the company’s own LD-2 reports, all issues, rounded to the nearest $10,000 each quarter. Two different filers, same 21 months.Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.

Lobbying spend by quarter since 2015Spend by quarter Pro

Free account See Pro

What they lobby on

Method

Emergent Biosolutions reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 6 outside firms. What follows is what the filings say it lobbied on, not which way.

Issue areas ranked by quarters filedQ4 24 → Q3 26

  • Budget/Appropriations8 of 88/8
  • Defense8 of 88/8
  • Disaster Planning/Emergencies8 of 88/8
  • Health Issues8 of 88/8
  • Homeland Security8 of 88/8
Aviation/Airlines/Airports 5 of 8 · Show all 6
  • Aviation/Airlines/Airports5 of 85/8

From the filings

“S. 4784, the FY27 National Defense Authorization Act provisions related to biological and chemical defense and access to naloxone.”
Q3 2026 filing · Defense
“Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield. Opioid and heroin addiction legislation, naloxone access and awareness.”
Q3 2026 filing · Budget/Appropriations

Contacted as listed on the filings

  • U.S. House
  • U.S. Senate
  • Health & Human ServicesHHS
  • Office of Management & BudgetOMB
  • Office of Natl Drug Control PolicyNDCP
  • White House Office
  • Food & Drug AdministrationFDA
  • Substance Abuse & Mental Health Services AdministrationSAMHSA

The House and Senate appear in every quarter; agencies in all 8 quarters.

Every filing since 2015, with the lobbyists named and the quarters each bill appearsEvery filing since 2015 Pro

Free account See Pro

Source: Lobbying Disclosure Act filings (LD-2) by Emergent Biosolutions, Senate Office of Public Records. Filings are due 20 days after each quarter ends.

From FEC filings: direct gifts this PAC reported, net of refunds · How we count

Gave directly to 16 sitting members of Congress and 1 other candidate in 2025–26.

Everyone this PAC fundsPro

See every candidate and member Emergent Biosolutions gave to directly, how much, and how its money splits between the parties.

This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.

Create a free account See what Pro adds Log in